questionText: To ask the Secretary of State for Health and Social Care, whether his Department plans to examine options for a separate evaluation process for orphan medicines claiming significant benefit over existing treatments.
answerText: There are no plans to introduce a separate evaluation process for orphan medicines. The National Institute for Health and Care Excellence (NICE) makes recommendations for the National Health Service on whether all new licensed medicines, including medicin...
heading: Orphan Drugs